Vita Life Sciences 配当と自社株買い

配当金基準チェック /46

Vita Life Sciences配当を支払う会社であり、現在の利回りは4.33%で、収益によって十分にカバーされています。

主要情報

4.3%

配当利回り

-0.6%

バイバック利回り

総株主利回り	3.7%
将来の配当利回り	n/a
配当成長	2.7%
次回配当支払日	n/a
配当落ち日	n/a
一株当たり配当金	AU$0.090
配当性向	55%

最近の配当と自社株買いの更新

Recent updates

決済の安定と成長

配当データの取得

安定した配当: VLSの配当金支払いは、過去10年間変動性が高かった。

増加する配当: VLSの配当金は過去10年間にわたって増加しています。

配当利回り対市場

Vita Life Sciences 配当利回り対市場

VLS 配当利回りは市場と比べてどうか？
セグメント	配当利回り
会社 (VLS)	4.3%
市場下位25% (AU)	2.6%
市場トップ25% (AU)	6.1%
業界平均 (Pharmaceuticals)	2.3%
アナリスト予想 (VLS) (最長3年)	n/a

注目すべき配当: VLSの配当金 ( 4.33% ) はAustralian市場の配当金支払者の下位 25% ( 2.63% ) よりも高くなっています。

高配当: VLSの配当金 ( 4.33% ) はAustralian市場の配当金支払者の上位 25% ( 6.14% ) と比較すると低いです。

株主への利益配当

収益カバレッジ: VLSの配当金は、合理的な配当性向 ( 54.9% ) により、利益によって賄われています。

株主配当金

キャッシュフローカバレッジ: VLSの現金配当性向 ( 48.3% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。

Vita Life Sciences 配当と自社株買い

配当金 基準チェック /46

主要情報

最近の配当と自社株買いの更新

Upcoming dividend of AU$0.06 per share

Upcoming dividend of AU$0.03 per share at 3.7% yield

Vita Life Sciences Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, 6 October 2023

Upcoming dividend of AU$0.033 per share at 3.9% yield

Upcoming dividend of AU$0.028 per share

Vita Life Sciences Limited Declares Fully Franked Interim Dividend for the Six Months Ended June 30, 2022, Payable on 7 October 2022

Recent updates

Less than half of directors are independent

Non-Executive Chairman recently sold AU$654k worth of stock

New minor risk - Insider selling

MD & Director recently sold AU$1.9m worth of stock

Upcoming dividend of AU$0.06 per share

Vita Life Sciences Limited, Annual General Meeting, May 15, 2024

Final dividend increased to AU$0.06

Full year 2023 earnings released: EPS: AU$0.17 (vs AU$0.13 in FY 2022)

Less than half of directors are independent

Vita Life Sciences Limited Provides Earnings Guidance for the Full Year Ending December 31, 2023

Less than half of directors are independent

Upcoming dividend of AU$0.03 per share at 3.7% yield

Less than half of directors are independent

Vita Life Sciences Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, 6 October 2023

Vita Life Sciences Limited Appoints Peter Osborne as an Independent Non-Executive Director

No independent directors

No independent directors

No independent directors

No independent directors

Full year 2022 earnings released: EPS: AU$0.13 (vs AU$0.16 in FY 2021)

Upcoming dividend of AU$0.033 per share at 3.9% yield

No independent directors

Full year 2022 earnings released: EPS: AU$0.13 (vs AU$0.16 in FY 2021)

No independent directors

No independent directors

No independent directors

No independent directors

Vita Life Sciences Provides Earnings Guidance for the Full Year Ending 31 December 2022

No independent directors

Less than half of directors are independent

Vita Life Sciences Limited Announces Board Changes, Effective 30 September 2022

Upcoming dividend of AU$0.028 per share

Vita Life Sciences Limited Declares Fully Franked Interim Dividend for the Six Months Ended June 30, 2022, Payable on 7 October 2022

First half 2022 earnings released: EPS: AU$0.069 (vs AU$0.07 in 1H 2021)

Less than half of directors are independent

Less than half of directors are independent

Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2022

Less than half of directors are independent

Upcoming dividend of AU$0.03 per share

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Vita Life Sciences Limited Announces Dividend for Six Months Ended December 31, 2021, Payable on April 7, 2022

Less than half of directors are independent

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Upcoming dividend of AU$0.028 per share

First half 2021 earnings released: EPS AU$0.07 (vs AU$0.058 in 1H 2020)

Less than half of directors are independent

Less than half of directors are independent

Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2021

Upcoming Dividend of AU$0.015 Per Share

Earnings released

決済の安定と成長

配当利回り対市場

株主への利益配当

株主配当金

高配当企業の発掘

配当金基準チェック /46